Skip to main content
Clinical Trials/NCT03260751
NCT03260751
Completed
Not Applicable

A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Zingiber Officinale Roscoe Extract on Body Fat

Chonbuk National University Hospital1 site in 1 country80 target enrollmentFebruary 3, 2017
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
Chonbuk National University Hospital
Enrollment
80
Locations
1
Primary Endpoint
Changes of body fat mass
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study was conducted to investigate the effects of daily supplementation of Zingiber officinale Roscoe extract on body fat.

Detailed Description

This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Forty subjects were randomly divided into Zingiber officinale Roscoe extract 200 mg or placebo group. The investigators measured Body Fat Mass, Percent Body Fat, Fat Free Mass, weight, and body mass index.

Registry
clinicaltrials.gov
Start Date
February 3, 2017
End Date
January 29, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Soo-Wan Chae

Principal investigator, Clinical Trial Center for Functional Foods

Chonbuk National University Hospital

Eligibility Criteria

Inclusion Criteria

  • age between 19 and 65 years,
  • BMI 25\~29.9 kg/m2
  • subjects giving written informed consent

Exclusion Criteria

  • Significant variation in weight(more 10%) in the past 3 months
  • Cardiovascular disease, e.g. arrhythmia, heart failure, myocardial infarction, and patient with pacemaker
  • History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease or gastrointestinal surgery
  • Participation in any other clinical trials within past 2 months
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • Pregnancy or breast feeding etc,.

Outcomes

Primary Outcomes

Changes of body fat mass

Time Frame: Baseline and 12 week

Body fat mass was measured in study baseline and 12 week

Secondary Outcomes

  • Changes of percent body fat(Baseline and 12 week)
  • Changes of fat free mass(Baseline and 12 week)
  • Changes of weight(Baseline and 12 week)
  • Changes of body mass index(Baseline and 12 week)

Study Sites (1)

Loading locations...

Similar Trials